CBP-201

Connect Biopharma celebrates a mid-stage win for its Dupixent rival, but shares tank after investors clamor for data
Endpoints
Fri, 11/19/21 - 11:10 am
Connect Biopharma
China
eczema
clinical trials
CBP-201
Dupixent